Related Experiment Video
Updated: Jun 12, 2026
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
Liver transplantation for primary or secondary endocrine tumors
Emilie Gregoire1, Yves Patrice Le Treut
1Department of Digestive Surgery and Liver Transplantation, Hôpital de La Conception, and Université de la Mediterranée, Marseille, France.
Abstract:
Endocrine tumors comprise a heterogeneous group of rare neoplasms. Liver metastatic endocrine tumors (MET) are amenable to various therapeutic modalities including liver transplantation (LT). However, LT for MET remains controversial because of the lack of clear selection criteria. The purpose of this study based on thorough perusal of English and French literature since 1989 was to identify prognostic factors and propose recommendations for selecting patients most likely to benefit LT for primary and secondary endocrine tumors.
Insights
Liver transplantation (LT) for metastatic endocrine tumors (MET) is controversial. This study identifies prognostic factors to guide patient selection for LT, aiming to improve outcomes for endocrine tumors.
Area of Science:
- Oncology
- Hepatology
- Transplantation
Background:
- Endocrine tumors are rare and heterogeneous neoplasms.
- Metastatic endocrine tumors (MET) to the liver can be treated with liver transplantation (LT).
- LT for MET is debated due to unclear patient selection criteria.
Purpose of the Study:
- To identify prognostic factors for liver transplantation in patients with endocrine tumors.
- To propose recommendations for selecting patients who will benefit most from LT for primary and secondary endocrine tumors.
Main Methods:
- Comprehensive literature review of English and French studies since 1989.
- Analysis of prognostic factors influencing LT outcomes in MET.
Main Results:
- Key prognostic indicators for LT in endocrine tumors were identified (details to be elaborated).
- Evidence-based recommendations for patient selection were formulated.
Conclusions:
- Establishing clear selection criteria is crucial for successful LT in MET.
- Optimizing patient selection can improve outcomes and reduce controversy surrounding LT for endocrine tumors.
